Orbimed Advisors LLC Pfizer Inc Call Options Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $6.32 Million - $7.4 Million	250,000 New	250,000 $7 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $13.1 Million - $17 Million	500,000 New	500,000 $14.4 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $23.8 Million - $27.9 Million	750,000 New	750,000 $27.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $15.1 Million - $18.3 Million	-500,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $13.5 Million - $19.3 Million	500,000 New	500,000 $16.3 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.